BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Javed A, Pal S, Dash NR, Ahuja V, Mohanti BK, Vishnubhatla S, Sahni P, Chattopadhyay TK. Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial. J Gastrointest Cancer 2012;43:63-9. [PMID: 20835926 DOI: 10.1007/s12029-010-9206-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer. Gastrointest Endosc 2012;76:267-74. [PMID: 22695208 DOI: 10.1016/j.gie.2012.04.442] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
2 Laskar SG, Lewis S, Agarwal JP, Mishra S, Mehta S, Patil P. Combined brachytherapy and external beam radiation: an effective approach for palliation in esophageal cancer. J Contemp Brachytherapy 2015;7:453-61. [PMID: 26816502 DOI: 10.5114/jcb.2015.56765] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
3 Lai A, Lipka S, Kumar A, Sethi S, Bromberg D, Li N, Shen H, Stefaniwsky L, Brady P. Role of Esophageal Metal Stents Placement and Combination Therapy in Inoperable Esophageal Carcinoma: A Systematic Review and Meta-analysis. Dig Dis Sci 2018;63:1025-34. [DOI: 10.1007/s10620-018-4957-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
4 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 McGinnis GJ, Holland JM, Thomas CR Jr, Nabavizadeh N. Massive hemorrhage following definitive esophageal chemoradiation: teaching case of a fatal aortoesophageal fistula and lessons learned. Clin Case Rep 2017;5:2074-9. [PMID: 29225860 DOI: 10.1002/ccr3.1239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Doosti-Irani A, Mansournia MA, Rahimi-Foroushani A, Haddad P, Holakouie-Naieni K. Complications of stent placement in patients with esophageal cancer: A systematic review and network meta-analysis. PLoS One. 2017;12:e0184784. [PMID: 28968416 DOI: 10.1371/journal.pone.0184784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
7 Doosti-Irani A, Mansournia MA, Cheraghi Z, Rahimi-Foroushani A, Haddad P, Holakouie-Naieni K. Network meta-analysis of palliative treatments in patients with esophageal cancer. Crit Rev Oncol Hematol 2021;168:103506. [PMID: 34740823 DOI: 10.1016/j.critrevonc.2021.103506] [Reference Citation Analysis]
8 van Rossum PSN, Mohammad NH, Vleggaar FP, van Hillegersberg R. Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends. Nat Rev Gastroenterol Hepatol. 2018;15:235-249. [PMID: 29235549 DOI: 10.1038/nrgastro.2017.162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
9 Lu YF, Chung CS, Liu CY, Shueng PW, Wu LJ, Hsu CX, Kuo DY, Hou PY, Chou HL, Leong KI, How CH, Chou SF, Wang LY, Hsieh CH. Esophageal Metal Stents with Concurrent Chemoradiation Therapy for Locally Advanced Esophageal Cancer: Safe or Not? Oncologist 2018;23:1426-35. [PMID: 29728468 DOI: 10.1634/theoncologist.2017-0646] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Levy A, Wagner AD, Chargari C, Moehler M, Verheij M, Durand-Labrunie J, Kissel M, Chirat E, Burtin P, Ducreux M, Boige V, Nilsson M, Boku N, Chau I, Deutsch E. Palliation of dysphagia in metastatic oesogastric cancers: An international multidisciplinary position. Eur J Cancer 2020;135:103-12. [PMID: 32563014 DOI: 10.1016/j.ejca.2020.04.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Buckle GC, Mahapatra R, Mwachiro M, Akoko L, Mmbaga EJ, White RE, Bent S, Van Loon K. Optimal management of esophageal cancer in Africa: A systemic review of treatment strategies. Int J Cancer 2021;148:1115-31. [PMID: 32930395 DOI: 10.1002/ijc.33299] [Reference Citation Analysis]
12 Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2009;CD005048. [PMID: 19821338 DOI: 10.1002/14651858.cd005048.pub4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
13 Grazziotin Reisner R, Reisner ML, Ferreira MA, Rosa AA, Veras IM, Carneiro TM, Wolff B, Viégas CM, Mendonça de Araújo CM, Marchiori E. Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy. Brachytherapy 2015;14:84-90. [PMID: 25447340 DOI: 10.1016/j.brachy.2014.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Ananthakrishnan N, Lakshmi C, Kate V. Esophageal stents in benign and malignant diseases. Asian Pacific Journal of Tropical Disease 2011;1:317-22. [DOI: 10.1016/s2222-1808(11)60074-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Borg D, Sundberg J, Brun E, Kjellén E, Petersson K, Hermansson M, Johansson J, Eberhard J, Johnsson A. Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial. Acta Oncol 2020;59:212-8. [PMID: 31564184 DOI: 10.1080/0284186X.2019.1670861] [Reference Citation Analysis]
16 Ramakrishnaiah VP, Malage S, Sreenath GS, Kotlapati S, Cyriac S. Palliation of Dysphagia in Carcinoma Esophagus. Clin Med Insights Gastroenterol 2016;9:11-23. [PMID: 27279758 DOI: 10.4137/CGast.S30303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hirdes MM, Siersema P. Endoprosthetics for malignant esophageal disease. Techniques in Gastrointestinal Endoscopy 2014;16:64-70. [DOI: 10.1016/j.tgie.2014.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Welsch J, Kup PG, Nieder C, Khosrawipour V, Bühler H, Adamietz IA, Fakhrian K. Survival and Symptom Relief after Palliative Radiotherapy for Esophageal Cancer. J Cancer 2016;7:125-30. [PMID: 26819634 DOI: 10.7150/jca.13655] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
19 Adamson D, Blazeby J, Porter C, Hurt C, Griffiths G, Nelson A, Sewell B, Jones M, Svobodova M, Fitzsimmons D, Nixon L, Fitzgibbon J, Thomas S, Millin A, Crosby T, Staffurth J, Byrne A. Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT. Health Technol Assess 2021;25:1-144. [PMID: 34042566 DOI: 10.3310/hta25310] [Reference Citation Analysis]
20 Puckett LL, Shukla ME. Sometimes less is more in palliating advanced oesophageal cancer. Lancet Gastroenterol Hepatol 2021;6:256-8. [PMID: 33714363 DOI: 10.1016/S2468-1253(21)00067-4] [Reference Citation Analysis]
21 Tinusz B, Soós A, Hegyi P, Sarlós P, Szapáry L, Erős A, Feczák D, Szakács Z, Márta K, Venglovecz V, Erőss B. Efficacy and safety of stenting and additional oncological treatment versus stenting alone in unresectable esophageal cancer: A meta-analysis and systematic review. Radiotherapy and Oncology 2020;147:169-77. [DOI: 10.1016/j.radonc.2020.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Williams GR, Manjunath SH, Butala AA, Jones JA. Palliative Radiotherapy for Advanced Cancers: Indications and Outcomes. Surg Oncol Clin N Am 2021;30:563-80. [PMID: 34053669 DOI: 10.1016/j.soc.2021.02.007] [Reference Citation Analysis]
23 Yamaguchi S, Ohguri T, Matsuki Y, Yahara K, Narisada H, Imada H, Korogi Y. Palliative radiotherapy in patients with a poor performance status: the palliative effect is correlated with prolongation of the survival time. Radiat Oncol 2013;8:166. [PMID: 23829540 DOI: 10.1186/1748-717X-8-166] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kim KY, Tsauo J, Song HY, Kim PH, Park JH. Self-Expandable Metallic Stent Placement for the Palliation of Esophageal Cancer. J Korean Med Sci 2017;32:1062-71. [PMID: 28581260 DOI: 10.3346/jkms.2017.32.7.1062] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
25 Spencer K, Parrish R, Barton R, Henry A. Palliative radiotherapy. BMJ 2018;360:k821. [PMID: 29572337 DOI: 10.1136/bmj.k821] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]